000 | 01956 a2200505 4500 | ||
---|---|---|---|
005 | 20250514201035.0 | ||
264 | 0 | _c20041006 | |
008 | 200410s 0 0 eng d | ||
022 | _a0006-291X | ||
024 | 7 |
_a10.1016/j.bbrc.2004.06.119 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHahm, Eun-Ryeong | |
245 | 0 | 0 |
_aSynthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. _h[electronic resource] |
260 |
_bBiochemical and biophysical research communications _cAug 2004 |
||
300 |
_a337-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xchemical synthesis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Movement |
650 | 0 | 4 | _aChick Embryo |
650 | 0 | 4 |
_aCurcumin _xanalogs & derivatives |
650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xgenetics |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 |
_aNeoplasms _xblood supply |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-jun _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xantagonists & inhibitors |
650 | 0 | 4 |
_aTranscription Factor AP-1 _xgenetics |
650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
650 | 0 | 4 |
_aUmbilical Cord _xpathology |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xgenetics |
700 | 1 | _aGho, Yong Song | |
700 | 1 | _aPark, Seyeon | |
700 | 1 | _aPark, Chihoon | |
700 | 1 | _aKim, Kyu-Won | |
700 | 1 | _aYang, Chul-Hak | |
773 | 0 |
_tBiochemical and biophysical research communications _gvol. 321 _gno. 2 _gp. 337-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2004.06.119 _zAvailable from publisher's website |
999 |
_c15053297 _d15053297 |